If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today

Group 1 - The core performance of Pfizer has been disappointing, with a $1,000 investment made on August 8, 2022, worth only $585 by August 8, 2025, compared to a $1,615 value for the S&P 500 index over the same period [1] - Future performance is crucial for current and potential investors, and Pfizer's outlook appears promising due to ongoing investments and strategic planning [2] - Past exceptional performance was driven by the COVID-19 vaccine and treatments, but demand has decreased, and several key products are losing patent protection soon [3] Group 2 - Pfizer is actively investing in its pipeline, which includes over 100 active programs, particularly in oncology, to counteract the loss of patent protection on major products [3] - The company has been receiving additional drug approvals and implementing cost-cutting measures to enhance profitability [3] - Pfizer offers a significant dividend yield of 7%, providing returns to investors while they await the benefits of the company's investments [4]